Article
Sickle cell disease: an inherited thrombophilia
2 Dec 2016
Abstract excerpt
Activation of the hemostatic system occurs in patients with sickle cell disease. The extent to which this activation contributes to sickle cell pathophysiology is uncertain. Clinical trials of anticoagulants or platelet inhibitors have demonstrated the ability to decrease biomarkers of hemostatic activation, but this has generally not resulted in improvement in clinically relevant outcomes. Venous thromboembolism...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
